戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 and activates PKD that remains predominantly sarcolemmal.
2 CO(3)(-) cotransporter (NBC) is an important sarcolemmal acid extruder in cardiac muscle.
3 ular buffering capacity, and the activity of sarcolemmal acid-extrusion proteins, Na+-H+ exchange (NH
4 ysiology themes have emerged: defects in (i) sarcolemmal and intracellular membrane remodelling and e
5 ), beta2-AR, and mu-opioid receptors in both sarcolemmal and intracellular membranes, whereas M2-mACh
6  GPCR, G-proteins, and AC with Cav-3 in both sarcolemmal and intracellular T-tubule-associated region
7 v-3 co-localized with AC5/6 and Galpha(s) in sarcolemmal and intracellular vesicles, the latter close
8                               The opening of sarcolemmal and mitochondrial ATP-sensitive K(+) (KATP)
9   Evidence exists for an involvement of both sarcolemmal and mitochondrial K(ATP) channels in such pr
10  the most important pathways responsible for sarcolemmal and mitochondrial sodium movements.
11 immunolabeled with fluorescent antibodies to sarcolemmal and myofibrillar markers, and examined with
12                 ROS production occurs in the sarcolemmal and t-tubule membranes where NOX2 is located
13  dynamic structures, present both at surface-sarcolemmal and transverse-tubular membranes.
14 uscle pathology compatible with targeting of sarcolemmal aquaporin-4 (AQP4) by complement-activating
15 y did not restore sarcolemmal nNOS (although sarcolemmal aquaporin-4 was restored).
16          Caveolae occupied around 50% of the sarcolemmal area predominantly assembled into multilobed
17 ed nNOSmu at similar levels does not lead to sarcolemmal association and fails to improve muscle func
18 ctin-4, and microtubules and is required for sarcolemmal association of these proteins as well as dys
19                                    Increased sarcolemmal ATP-sensitive K(+) (K(ATP)) channel subunit
20 bunit of metabolic-sensing, cardioprotective sarcolemmal ATP-sensitive K(+) (K(ATP)) channels.
21 tion is tightly coupled to the activation of sarcolemmal ATP-sensitive K(+) channels, hastening actio
22 tion triggered by oxidative stress activates sarcolemmal ATP-sensitive K(+) currents to form a metabo
23 bolites of arachidonic acid (AA), are potent sarcolemmal ATP-sensitive K+ (KATP) channel activators.
24          Twenty years after the discovery of sarcolemmal ATP-sensitive K+ channels and 12 years after
25 oding the Kir6.2 pore-forming subunit of the sarcolemmal ATP-sensitive potassium (K(ATP)) channel, pr
26 gen species (ROS), coupled to the opening of sarcolemmal ATP-sensitive potassium (K(ATP)) channels, c
27 ed in mice lacking the Kir6.2 subunit of the sarcolemmal ATP-sensitive potassium (sK(ATP)) channel af
28                                    ABSTRACT: Sarcolemmal ATP-sensitive potassium channel (KATP channe
29                                              Sarcolemmal ATP-sensitive potassium channels (K(ATP)) ac
30                                              Sarcolemmal ATP-sensitive potassium channels (KATP chann
31 tional sequelae, including redistribution of sarcolemmal beta(2)-adrenergic receptors (beta(2)AR) and
32  excitation-contraction coupling between the sarcolemmal Ca(2+) channels and mutated RyR2(R4496C+/-)
33 stolic sarcoplasmic reticulum Ca(2+) leak or sarcolemmal Ca(2+) entry may raise local [Ca(2+)]Cleft a
34 [Ca(2+)] ([Ca(2+)](rest)), increased resting sarcolemmal Ca(2+) entry, and decreased sarcoplasmic ret
35 pecific activation of A(1)AR by CCPA induced sarcolemmal Ca(2+) entry.
36 rcoplasmic reticulum Ca(2+) leak rather than sarcolemmal Ca(2+) flux.
37 reactive oxygen species (ROS) production and sarcolemmal Ca(2+) influx are early indicators of diseas
38       In addition, we demonstrate that basal sarcolemmal Ca(2+) influx is also governed by RyR1 expre
39 id), evoked a [Ca(2+)]i rise, independent of sarcolemmal Ca(2+) influx or release from mitochondria,
40   Store-operated Ca(2+) entry (SOCE) through sarcolemmal Ca(2+) selective Orai1 channels in complex w
41 (2+) leak causes an enlarged basal influx of sarcolemmal Ca(2+) that results in chronically elevated
42 tion involves rapid, dynamic augmentation of sarcolemmal Ca(V) 1.2 channel abundance after ISO applic
43 l concept that a pre-synthesized pool of sub-sarcolemmal Ca(V) 1.2 channel-containing vesicles/endoso
44 y membrane voltage (through its influence on sarcolemmal Ca2+ currents) and, therefore, by all ionic
45                                        Trans-sarcolemmal Ca2+ entries were measured fluorometrically
46 ced positive inotropic effect via inhibiting sarcolemmal Ca2+ influx and the subsequent increase in i
47 a+-Ca2+ exchanger (NCX1) is one of the major sarcolemmal Ca2+ transporters of cardiomyocytes.
48             The sodium-calcium exchanger and sarcolemmal calcium ATPase had a lower activity and the
49 r was responsible for a larger proportion of sarcolemmal calcium extrusion in smaller cells compared
50 ated cellular calcium loads due to a reduced sarcolemmal calcium extrusion reserve.
51  uptake which was balanced by enhanced trans-sarcolemmal calcium fluxes (calcium current and sodium/c
52 ssed SR Ca(2+) sequestration, enhanced trans-sarcolemmal calcium fluxes, and AF, establishing a mecha
53  of the sarcoplasmic reticulum and decreased sarcolemmal calcium permeability at rest and after SOCE
54     There is increasing evidence placing the sarcolemmal calcium pump, or plasma membrane calcium/cal
55 hysiology by demonstrating that nonselective sarcolemmal cation channel activity plays a critical rol
56                                  Nonspecific sarcolemmal cation channels are critical for the pathoge
57  SR Ca(2+) indicator), IP(3) activated 15 pS sarcolemmal cation channels, generated a whole-cell cati
58             With time, the number of surface-sarcolemmal caveolae decreases in isolated cardiomyocyte
59  After cell isolation, the number of surface-sarcolemmal caveolae decreases significantly within a ti
60     The presence and distribution of surface-sarcolemmal caveolae in freshly isolated cells matches t
61 gests that membrane incorporation of surface-sarcolemmal caveolae underlies this, but internalization
62 rom hypoxia-induced cell death and increased sarcolemmal caveolae.
63                                              Sarcolemmal CD36 facilitates myocardial fatty acid (FA)
64                                        Thus, sarcolemmal CD36 has a key role in muscle fuel selection
65 d entry into muscle occurs via a regulatable sarcolemmal CD36-mediated mechanism.
66                        ClC-1 is the dominant sarcolemmal chloride channel and plays an important role
67  myotonic discharges coupled with deficit in sarcolemmal chloride channels, required regulators of hy
68 indings are consistent with the reduction of sarcolemmal chloride conductance that occurs upon acidif
69 generation, apoptosis, inflammation, loss of sarcolemmal complexes, sarcolemmal disruption, and ultra
70 myotendinous junctions, suggesting a role at sarcolemmal contacts with extracellular matrix.
71                           Concomitantly, the sarcolemmal content of the glucose transporter, GLUT4, i
72 novel pathways by which RyR2 channels engage sarcolemmal currents to produce life-threatening arrhyth
73 ot undermined by RRNYRRNY-related opening of sarcolemmal Cx43 channels.
74 lysis reveals the complex interdependence of sarcolemmal, cytoplasmic, and mitochondrial processes th
75 of the dystroglycan complex (DCG) within the sarcolemmal cytoskeleton.
76            Notably, ERRgamma did not restore sarcolemmal DAG complex, which is thus dispensable for a
77 The fibrosis-entrapped cardiomyocytes showed sarcolemmal damage and connexin 43 redistribution/intern
78 phy-associated Caveolin-3 mutant both led to sarcolemmal damage but only in response to vigorous musc
79              Repair of skeletal muscle after sarcolemmal damage involves dysferlin and dysferlin-inte
80 n-deficient muscles, significantly preceding sarcolemmal damage that becomes evident at 7 dpf.
81 e we show that Thbs3 antithetically promotes sarcolemmal destabilization by reducing integrin functio
82 is unlikely associated with the stability of sarcolemmal DGC and integrin complexes.
83 avage-resistant dystrophin had a decrease in sarcolemmal disruption and cardiac virus titer following
84 ngth annexin A6 to the site of laser-induced sarcolemmal disruption compared to Dysf(129) myofibers,
85 inflammation, loss of sarcolemmal complexes, sarcolemmal disruption, and ultrastructural changes char
86  tight electrical coupling between different sarcolemmal domains is guaranteed only within an intact
87 pletion of ankyrin-B and resulted in loss of sarcolemmal dystrophin, dystroglycan, and microtubules.
88 ation status of dystroglycan from within the sarcolemmal dystrophin-glycoprotein complex.
89 g the balance of Ca2+ fluxes away from trans-sarcolemmal efflux toward SR accumulation.
90 ubular (t)-system of skeletal muscle couples sarcolemmal electrical excitation with contraction deep
91 Ischemia is known to inhibit the function of sarcolemmal enzymes, including the (Na+ + K+)-ATPase, bu
92          This injected biglycan restores the sarcolemmal expression of alpha-dystrobrevin-1 and -2, a
93 During ischemia, there was a 32% decrease in sarcolemmal FAT/CD36 accompanied by a 95% decrease in fa
94             Following reperfusion, decreased sarcolemmal FAT/CD36 persisted, but fatty acid oxidation
95 ing the dystrophin-glycoprotein complex, and sarcolemmal FKRP immunofluorescence mirrors that of dyst
96 valence of Kir6.2 and SUR2 was higher in the sarcolemmal fractions of females (Kir6.2: F, 1.24 +/- 0.
97 addition, these mutant mice displayed marked sarcolemmal fragility and reduced muscle exercise tolera
98 er cachexia, including muscle fiber atrophy, sarcolemmal fragility, and impaired muscle regeneration.
99   Moreover, contraction-induced increases in sarcolemmal GLUT4 content and glucose uptake were lower
100                                     Elevated sarcolemmal GLUT4 persisted during reperfusion; in contr
101 ncrease abundance of alpha-DG and associated sarcolemmal glycoproteins, increase utrophin usage, and
102 k cortical actin filaments with a complex of sarcolemmal glycoproteins, yet localize to different sub
103 sistent with increased abundance of multiple sarcolemmal glycoproteins.
104 s cell-to-cell H(+) movement, while allowing sarcolemmal H(+) transporters such as Na(+)/H(+) exchang
105 er mechanisms to lower heart rate, including sarcolemmal hyperpolarization-activated current (I f) an
106                                 Increases in sarcolemmal immunolabelling for utrophin and beta-dystro
107 ese group of diseases is defective repair of sarcolemmal injuries, which normally requires Ca(2+) sen
108 size and repair of myofibers following focal sarcolemmal injury and lengthening contraction injury.
109 y cells other than cardiomyocytes can induce sarcolemmal injury during MI.
110 atively affects cardiac myocytes by inducing sarcolemmal injury, generating reactive aldehydes, formi
111 o and in vivo and reduced Cfb expression and sarcolemmal injury.
112                                This leads to sarcolemmal instability and Ca(2+) influx, inducing cell
113          VPA-treated mice also had increased sarcolemmal integrity and decreased damage, decreased CD
114        Loss of dystrophin results in reduced sarcolemmal integrity and increased susceptibility to mu
115 tary, but nonredundant, roles in maintaining sarcolemmal integrity and protecting skeletal muscle fib
116 sal lamina contributes to the maintenance of sarcolemmal integrity and protects muscles from damage.
117 nges were not associated with alterations in sarcolemmal integrity as measured by muscle fiber uptake
118 taining with Evans blue dye revealed loss of sarcolemmal integrity in both lines of mice, similar to
119                                  Compromised sarcolemmal integrity is directly shown in Large(myd) mu
120  an intact DGC is not a precondition for EOM sarcolemmal integrity, and active adaptation at the leve
121 duced serum creatine kinase levels, improved sarcolemmal integrity, fewer centralized myonuclei, incr
122 esponding deleted sarcoglycan gene preserved sarcolemmal integrity, prevented pathological dystrophy
123 dystrophin at costameres, and maintenance of sarcolemmal integrity.
124 h the extracellular matrix (ECM) to preserve sarcolemmal integrity.
125 cantly reduced cardiac fibrosis and improved sarcolemmal integrity.
126      At the cell level, a complex network of sarcolemmal invaginations, called the transverse-axial t
127 elopathy caused by dysfunction of one of two sarcolemmal ion channels, either the sodium channel Nav1
128 ory is associated with altered expression of sarcolemmal ion channels, the biophysical mechanisms res
129                         Among the panoply of sarcolemmal ionic currents investigated (I(Na)(+)/I(CaL)
130 repolarization via LOX-1-mediated alteration sarcolemmal ionic currents.
131 in Tr5HD and Sed5HD, respectively); however, sarcolemmal K(ATP) blockade completely eradicated the tr
132                    SSC is dependent upon the sarcolemmal K(ATP) channel (sarcK(ATP)), and protein kin
133 ignificant increases in both subunits of the sarcolemmal K(ATP) channel following training.
134 BCC9) subunits are essential elements of the sarcolemmal K(ATP) channel in cardiac ventricular myocyt
135                                 Although the sarcolemmal K(ATP) channel is a multiprotein complex com
136  by 5HD; (2) pharmacological blockade of the sarcolemmal K(ATP) channel nullified the cardioprotectiv
137 subjected to pharmacological blockade of the sarcolemmal K(ATP) channel with HMR 1098 (SedHMR and TrH
138 rise entirely from reduced expression of the sarcolemmal K(ATP) channel, but we also discuss the poss
139 time RT-PCR has demonstrated that of all six sarcolemmal K(ATP) channel-forming proteins, SUR2A was p
140                         Classically, cardiac sarcolemmal K(ATP) channels are thought to be composed o
141                  We demonstrate that cardiac sarcolemmal K(ATP) channels directly associate with anky
142                                  The role of sarcolemmal K(ATP) channels in Tr-induced protection was
143                       An increased number of sarcolemmal K(ATP) channels seems to protect the heart b
144 riction in the wild-type and in mice lacking sarcolemmal K(ATP) channels through Kir6.2 pore knockout
145 se training; and (3) increased expression of sarcolemmal K(ATP) channels was observed following chron
146 limiting factor in generating fully composed sarcolemmal K(ATP) channels.
147 vels is sufficient to increase the number of sarcolemmal K(ATP) channels.
148 ue at least in part to increase in levels of sarcolemmal K(ATP) channels.
149 s an increased protein expression of cardiac sarcolemmal K(ATP) channels.
150                   This suggests differential sarcolemmal K(ATP) composition in atria and ventricles,
151  and electrical excitability mediated by the sarcolemmal K(ATP) current (I(K,ATP)).
152  residues 1294-1358, the A-fragment, reduced sarcolemmal K(ATP) currents by over 85% after 2 days (pi
153 g mechanism responsible for NO modulation of sarcolemmal KATP (sarcKATP) channels in ventricular card
154 ntal protocol, suggested that the opening of sarcolemmal KATP channels at the beginning of sustained
155 lamp experiments that revealed activation of sarcolemmal KATP channels by preconditioning.
156 sed contracting rabbit hearts to assess when sarcolemmal KATP channels were activated during physiolo
157 ediated by the activation and trafficking of sarcolemmal KATP channels.
158 getics were tightly coupled to activation of sarcolemmal KATP currents, causing oscillations in actio
159 target of beta-adrenergic stimulation is the sarcolemmal L-type Ca(2+) channel, CaV1.2, which plays a
160      Inducible transgenic mice with enhanced sarcolemmal L-type Ca2+ channel (LTCC) activity showed p
161     EET-induced Ca2+ sparks activated nearby sarcolemmal large-conductance Ca2+-activated K+ (BKCa) c
162 ents that revealed a significantly increased sarcolemmal lateral stiffness.
163 mplex and the alpha7beta1 integrin are trans-sarcolemmal linkage systems that connect and transduce c
164  evidence for an ankyrin-based mechanism for sarcolemmal localization of dystrophin and beta-DG.
165    Ankyrin-B thus is an adaptor required for sarcolemmal localization of dystrophin, as well as dynac
166 mutation reduces ankyrin binding and impairs sarcolemmal localization of dystrophin-Dp71.
167                                              Sarcolemmal localization of gamma-SG was achieved regard
168   In the present study, we hypothesized that sarcolemmal localization of nNOS is a critical determina
169 direct role in regulating the expression and sarcolemmal localization of the intracellular signaling
170             R10-12 showed both cytosolic and sarcolemmal localization.
171                   Aside from the benefits of sarcolemmal-localized NO production, NOS-M also increase
172 n skeletal muscle, where it is important for sarcolemmal maintenance.
173    Duchenne muscular dystrophy (DMD) induces sarcolemmal mechanical instability and rupture, hyperact
174 nels therefore defines whether junctional or sarcolemmal mechanisms are selected locally for the remo
175 ed to the effect that preconditioning has on sarcolemmal membrane action potential as revealed by di-
176  the couplon where L-type Ca channels in the sarcolemmal membrane adjoin ryanodine receptors in the s
177 ne or angiotensinII causes GRK5 to leave the sarcolemmal membrane and accumulate in the nucleus, whil
178 , which is associated with disruption of the sarcolemmal membrane and cleavage of dystrophin with pro
179 ifier locus on chromosome 11 associated with sarcolemmal membrane damage and heart mass.
180 MD-like zebrafish, but failed to reverse the sarcolemmal membrane damage.
181 suggest that ANO5 plays an important role in sarcolemmal membrane dynamics.
182           We conclude that the presence of a sarcolemmal membrane either at the cell periphery or in
183  (PDE-5)-hydrolyzable cGMP undetected at the sarcolemmal membrane in contrast to cGMP stimulated by n
184 roglycan were highly overexpressed along the sarcolemmal membrane in most DG/mdx muscles.
185 of muscular dystrophy arise from compromised sarcolemmal membrane integrity, a therapeutic approach t
186 in modulating the confinement of VDCC within sarcolemmal membrane nanodomains in response to varying
187 ation, the cytokeratins are disrupted at the sarcolemmal membrane of skeletal muscle of the mdx mouse
188 -GSK-3beta to regulate mitochondrial but not sarcolemmal membrane potential.
189  background significantly increased myofiber sarcolemmal membrane stability with greater expression a
190 ate that isoflurane modifies cardiac myocyte sarcolemmal membrane structure and composition and that
191 etween activation of IP(3)R and RyR near the sarcolemmal membrane.
192 y associated with intracellular vesicles and sarcolemmal membrane.
193 nced vesicle trafficking to and budding from sarcolemmal membrane.
194 line and M-line domains at costameres at the sarcolemmal membrane.
195     Adenylyl cyclase activity was blunted in sarcolemmal membranes after stretch, demonstrating beta-
196 d progressive changes in tubuloreticular and sarcolemmal membranes and mislocalized triads and mitoch
197 cilitate stabilization and repair of damaged sarcolemmal membranes following myocardial injury.
198 r were compared with muscarinic receptors in sarcolemmal membranes for the effect of guanosine 5'-[be
199 no acid transporter activity were similar in sarcolemmal membranes isolated from control and IUGR hin
200 tivity and Na(+) K(+) -ATPase activity using sarcolemmal membranes isolated from hindlimb muscle of c
201 s decreasing membrane excitability, injuring sarcolemmal membranes, altering calcium homeostasis due
202 ure results in mistargeting of the kinase to sarcolemmal membranes, causing severe excitation-contrac
203              With tetramers and receptors in sarcolemmal membranes, GMP-PNP effected a vertical, upwa
204 d as determined by radioligand binding in LV sarcolemmal membranes.
205 with abnormalities of intercalated discs and sarcolemmal membranes.
206 cts at tetramers in vesicles or receptors in sarcolemmal membranes.
207                                  Recovery of sarcolemmal microstructure correlated with functional be
208 d microtubules and also is required to align sarcolemmal microtubules with costameres.
209 se in area, diameter, and circularity of sub-sarcolemmal mitochondria, indicative of swelling.
210  (SV2), encoded by the SVIL gene, is a large sarcolemmal myosin II- and F-actin-binding protein.
211 rdiac myocytes is slow with respect to trans-sarcolemmal Na transport rates, although the mechanisms
212             We speculate that reduced muscle sarcolemmal Na(+) K(+) -ATPase activity and lower ATP co
213 n of enhanced IICR and increased activity of sarcolemmal Na(+)-Ca(2+) exchange depolarizing the cell
214 ty, in part through an effect on the cardiac sarcolemmal Na(+)/Ca(2+) exchanger (NCX), but little is
215                                              Sarcolemmal Na(+)/H(+) exchanger (NHE) activity is media
216 otein-coupled receptor stimulation increases sarcolemmal Na(+)/H(+) exchanger (NHE1) activity in card
217                                          The sarcolemmal Na+-Ca2+ exchanger (NCX) is the main Ca2+ ex
218                                  The cardiac sarcolemmal Na+-Ca2+ exchanger (NCX1) influences cardiac
219  entry is balanced by efflux mediated by the sarcolemmal Na+-Ca2+ exchanger.
220 ne-induced Ca2+ transient, implying impaired sarcolemmal Na+/Ca2+ exchanger function.
221                                              Sarcolemmal Na/Ca exchange (NCX) regulates cardiac Ca an
222 e have observed a profound activation of the sarcolemmal Na/K ATPase during cardiac ischemia, which i
223 ggest nonselective ion channel transport via sarcolemmal nanopores as a triggering mechanism.
224 e-induced inactivity correlates with loss of sarcolemmal neuronal NOS localization in mdx muscle, whe
225 -mediated phosphorylation at Ser648 inhibits sarcolemmal NHE activity during intracellular acidosis,
226 naptic nNOS but surprisingly did not restore sarcolemmal nNOS (although sarcolemmal aquaporin-4 was r
227  recapitulates the vasoregulatory actions of sarcolemmal nNOS in BMD patients, and constitutes a puta
228 chenne muscular dystrophy (DMD), the loss of sarcolemmal nNOS leads to functional ischemia and muscle
229                                              Sarcolemmal nNOS staining was decreased in patient biops
230 phin on the membrane does not always restore sarcolemmal nNOS.
231 , both of which are characterized by reduced sarcolemmal nNOS.
232                We have previously shown that sarcolemmal nNOSmu matches the blood supply to the metab
233 ere, we investigated the effect of restoring sarcolemmal nNOSmu on muscle contractile function in mdx
234   When healthy skeletal muscle is exercised, sarcolemmal nNOSmu-derived nitric oxide (NO) attenuates
235 ith SIT or ET, while neither endothelial nor sarcolemmal NOX2 was changed.
236 ), the respective blockers of mitochondrial, sarcolemmal, or both types of K(ATP) channels prior to S
237 ther aspects of the synaptic and nonsynaptic sarcolemmal organization of EOM fiber types may underlie
238 -/-) muscle fibers showed a striking loss of sarcolemmal organization, aberrant T-tubule structures,
239 inflammatory cell infiltration and increased sarcolemmal permeability.
240  that phospholemman (PLM), a 15-kDa integral sarcolemmal phosphoprotein, inhibits the cardiac Na+/Ca2
241  that phospholemman (PLM), a 15-kDa integral sarcolemmal phosphoprotein, is a novel endogenous protei
242                           Phosphorylation of sarcolemmal PKC was reduced by Chel (p-PKC/PKC: control,
243 s entirely PKD-dependent, involving fleeting sarcolemmal PKD translocation (for activation) and very
244 from proteasomal degradation, an increase in sarcolemmal plectin appeared to confer protection on Dag
245  data, we suggest a new model in which a sub-sarcolemmal pool of pre-synthesized Ca(V) 1.2 channels r
246 tion potential as revealed by di-8-ANEPPS, a sarcolemmal-potential sensitive dye, and laser confocal
247                   These results suggest that sarcolemmal processes are responsible for the reduced sp
248 matory molecules and augmented the levels of sarcolemmal protein beta-dystroglycan and neuronal nitri
249                                          The sarcolemmal protein phospholemman (PLM) was found associ
250                    Dystrophin is a large sub-sarcolemmal protein.
251  acids in mice to study acute changes in the sarcolemmal proteome in early phase of myofiber injury.
252              We have implemented an improved sarcolemmal proteomics approach together with in vivo la
253 es in cell morphology, impaired formation of sarcolemmal protrusions, and defective cell motility.
254 omyocytes (NRCMs) transduced with GFP showed sarcolemmal, punctate Cx43 expression.
255 rotocols recruit a complex signal cascade of sarcolemmal receptor activation, intracellular enzyme ac
256               Nedd4 protein localized to the sarcolemmal region of muscle fibers.
257 heral muscle and cardiac tissue, with robust sarcolemmal relocalization of the dystrophin-associated
258 ily, glucocorticoid steroid regimen promotes sarcolemmal repair and muscle recovery from injury while
259 bodies from these same serum samples rescues sarcolemmal repair capacity.
260                              Here we examine sarcolemmal repair in live zebrafish embryos by real-tim
261 ve transfer mouse model of IIM, we show that sarcolemmal repair is significantly compromised in dista
262                                A compromised sarcolemmal repair process could promote an aberrant exp
263 le pulse of glucocorticoid steroids improved sarcolemmal repair through increased expression of annex
264 e assessed the efficacy of steroid dosing on sarcolemmal repair, muscle function, histopathology, and
265 ted levels of TRIM72 autoantibodies suppress sarcolemmal resealing in healthy skeletal muscle, and de
266 emma, whereas isoproterenol triggered faster sarcolemmal responses than cytosolic, likely due to rest
267                                              Sarcolemmal rupture was evident in 10.9% of fibers in LV
268                               In adult VCMs, sarcolemmal (sarc) and mitochondrial (mito) ATP-sensitiv
269  and a subset of microtubules disappear from sarcolemmal sites in ankyrin-B-depleted muscle.
270  pattern in which nerves terminate at select sarcolemmal sites often localized to the central region
271 sed to investigate whether inhibition of the sarcolemmal sodium-hydrogen exchanger isoform-1 (NHE-1)
272                            Inhibition of the sarcolemmal sodium-hydrogen exchanger isoform-1 (NHE-1)
273                     This results in improved sarcolemmal stability and prevents dystrophic pathology
274 ct striated muscle from disease by enhancing sarcolemmal stability through increased integrin and dys
275 uscle pathology, reduced fibrosis, increased sarcolemmal stability, and promoted muscle regeneration
276  predisposing effects of Thbs3 by augmenting sarcolemmal stability.
277 ate for the primary defects of DMD restoring sarcolemmal stability.
278 expression improves dystrophic pathology and sarcolemmal stability.
279 d) Ca2+ sparks occurred within 1 microm of a sarcolemmal structure (cell periphery or TATS), and 33 %
280                 In summary, abnormalities of sarcolemmal structure in heart failure show plasticity w
281 howed improved contractility and reversal of sarcolemmal structure.
282 es have highlighted various cytoskeletal and sarcolemmal structures in cardiac myocytes as the likely
283 f the t-system and dissociation of RyRs from sarcolemmal structures in lateral cells.
284  Simultaneous measurement of Ca2+ sparks and sarcolemmal structures showed that cells without TATS ha
285                   PLM (FXYD1) is the primary sarcolemmal substrate for PKC and PKA in the heart.
286 spholemman (PLM), the principal quantitative sarcolemmal substrate for protein kinases A and C in the
287           Phospholemman (PLM), the principal sarcolemmal substrate for protein kinases A and C in the
288 hese proteins is nonuniform between the bulk sarcolemmal surface and membrane invaginations known as
289 ndicated that they occupy ~16 and ~5% of the sarcolemmal surface in myofibers and cardiocytes, respec
290 dystrophin deletion constructs, we show that sarcolemmal targeting of nNOS was dependent on the spect
291 e mainly in patients whose mutations disrupt sarcolemmal targeting of nNOSmu, with the vasoconstricto
292 peats 16 and 17 as a novel scaffold for nNOS sarcolemmal targeting.
293 and the adaptor protein alpha-syntrophin for sarcolemmal targeting.
294  and ceramides or suppress muscle PKCepsilon sarcolemmal translocation in db/db mice.
295 nuclear activation of PKD, without preceding sarcolemmal translocation.
296                           ATPase activity in sarcolemmal vesicles also showed a lower Km(Na) in PLM-K
297                                          The sarcolemmal voltage gated sodium channel Na(V)1.4 conduc
298 c myocytes increases the open probability of sarcolemmal voltage-sensitive Ca2+ channels and flux of
299 tein complex, leading to contraction-induced sarcolemmal weakening, muscle tearing, fibrotic infiltra
300 bution of the annexins and the efficiency of sarcolemmal wound-healing are significantly disrupted in

 
Page Top